Overview

Efficacy and Safety of Synthetic Phosphoethanolamine in Solid Tumor Patients

Status:
Terminated
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
Synthetic phosphoethanolamine is a primary amine which has a critical role in the biosynthesis of cell membranes. Pre-clinical models have shown potential anticancer activity.
Phase:
Phase 2
Details
Lead Sponsor:
Secretaria de Estado da Saúde
Collaborator:
Instituto do Cancer do Estado de São Paulo